En-tête de navigationNavigation principaleSuiviFiche


Unité de recherche
PCRD EU
Numéro de projet
04.0009
Titre du projet
GA2LEN: Global allergy and asthma European network
Titre du projet anglais
GA2LEN: Global allergy and asthma European network

Textes relatifs à ce projet

 AllemandFrançaisItalienAnglais
Mots-clé
-
-
-
Anzeigen
Autre Numéro de projet
-
-
-
Anzeigen
Programme de recherche
-
-
-
Anzeigen
Description succincte
-
-
-
Anzeigen
Autres indications
-
-
-
Anzeigen
Résumé des résultats (Abstract)
-
-
-
Anzeigen
Références bases de données
-
-
-
Anzeigen

Textes saisis


CatégorieTexte
Mots-clé
(Anglais)
Asthma; network of excellence
Autre Numéro de projet
(Anglais)
EU project number: 506378
Programme de recherche
(Anglais)
EU-programme: 6. Frame Research Programme - 1.5 Urspr. Progr. Food quality and safety
Description succincte
(Anglais)
See abstract
Autres indications
(Anglais)
Full name of research-institution/enterprise:
Schweizerisches Institut für Allergie- und Asthmaforschung
Immunologie
Résumé des résultats (Abstract)
(Anglais)
Allergic diseases and asthma pose an important and increasing problem for Europe. European research groups already make a major contribution to studies of the causes and management of these conditions. Initiatives from the European Commission have led to increasing collaboration within Europe, but there is still a lack of permanent structures, and there are relatively poor links between disciplines. A network of excellence (NoE) will be the optimal answer to these problems.
GA2LEN (Global Allergy and Asthma European Network) is a NoE of 25 leading European teams, the European Academy of Allergology and Clinical Immunology (EMCI) and a patient's organisation (EFA). The objective is to establish an internationally competitive network, to enhance the quality and relevance of research, address all aspects of the disease, and eventually to decrease the burden of allergy and asthma throughout Europe.
The network will bring together epidemiological, basic and clinical researchers carefully considering ethical and gender issues. It will investigate allergy and asthma across the life course, including intra-uterine life and foeto-maternal interface; interaction between genetic and environmental factors in early life, translation of allergic sensitisation into disease, and persistence of the disease. This will allow development of novel biomarkers, treatments and preventive strategies.
GA2LEN will create a permanent and durable structure that will maximize the scientific contribution of Europe to this area. The network will accelerate the application of research results to clinical practice, patients' needs and policy development, as well as promoting training and integration between public and private sectors.
Références bases de données
(Anglais)
Swiss Database: Euro-DB of the
State Secretariat for Education and Research
Hallwylstrasse 4
CH-3003 Berne, Switzerland
Tel. +41 31 322 74 82
Swiss Project-Number: 04.0009